- Home
- GROV vs PEPG Comparison
GROV vs PEPG Comparison
Compare GROV & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- PEPG
- Stock Information
- Founded
- GROV 2016
- PEPG 2018
- Country
- GROV United States
- PEPG United States
- Employees
- GROV N/A
- PEPG N/A
- Industry
- GROV Package Goods/Cosmetics
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- PEPG Health Care
- Exchange
- GROV Nasdaq
- PEPG Nasdaq
- Market Cap
- GROV 57.6M
- PEPG 52.4M
- IPO Year
- GROV N/A
- PEPG 2022
- Fundamental
- Price
- GROV $1.39
- PEPG $1.53
- Analyst Decision
- GROV Hold
- PEPG Buy
- Analyst Count
- GROV 1
- PEPG 3
- Target Price
- GROV $1.20
- PEPG $7.67
- AVG Volume (30 Days)
- GROV 113.2K
- PEPG 216.8K
- Earning Date
- GROV 05-14-2025
- PEPG 05-08-2025
- Dividend Yield
- GROV N/A
- PEPG N/A
- EPS Growth
- GROV N/A
- PEPG N/A
- EPS
- GROV N/A
- PEPG N/A
- Revenue
- GROV $193,427,000.00
- PEPG N/A
- Revenue This Year
- GROV N/A
- PEPG N/A
- Revenue Next Year
- GROV $6.19
- PEPG N/A
- P/E Ratio
- GROV N/A
- PEPG N/A
- Revenue Growth
- GROV N/A
- PEPG N/A
- 52 Week Low
- GROV $1.02
- PEPG $0.88
- 52 Week High
- GROV $1.95
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- GROV 59.55
- PEPG 51.32
- Support Level
- GROV $1.30
- PEPG $1.40
- Resistance Level
- GROV $1.41
- PEPG $1.73
- Average True Range (ATR)
- GROV 0.10
- PEPG 0.16
- MACD
- GROV 0.02
- PEPG 0.00
- Stochastic Oscillator
- GROV 77.72
- PEPG 50.00
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.